Safety issues and harmful pharmacological interactions of nutritional supplements in Duchenne muscular dystrophy: considerations for Standard of Care and emerging virus outbreaks

At the moment, little treatment options are available for Duchenne muscular dystrophy (DMD). The absence of the dystrophin protein leads to a complex cascade of pathogenic events in myofibres, including chronic inflammation and oxidative stress as well as altered metabolism. The attention towards di...

Descripción completa

Detalles Bibliográficos
Autores principales: Boccanegra, Brigida, Verhaart, Ingrid E.C., Cappellari, Ornella, Vroom, Elizabeth, De Luca, Annamaria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261230/
https://www.ncbi.nlm.nih.gov/pubmed/32485610
http://dx.doi.org/10.1016/j.phrs.2020.104917

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261230/
https://www.ncbi.nlm.nih.gov/pubmed/32485610
http://dx.doi.org/10.1016/j.phrs.2020.104917

Ejemplares similares